Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q0249. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
19
Median % of Medicare
--
Rate range
$5.96 - $7.57
Q0249 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $6.57 | -- | -- | 2026 |
| Arizona | $7.57 | -- | -- | 2026 |
| District of Columbia | $7.57 | -- | Not required | 2025 |
| Georgia | $6.57 | -- | -- | 2026 |
| Iowa | $5.96 | -- | -- | 2024 |
| Idaho | $6.54 | -- | Not required | 2025 |
| Indiana | $6.97 | -- | -- | 2023 |
| Maryland | $7.56 | -- | -- | 2021 |
| Mississippi | $7.57 | -- | -- | 2025 |
| Montana | $7.57 | -- | -- | 2026 |
| Nebraska | $7.56 | -- | -- | 2026 |
| New Hampshire | $6.64 | -- | Not required | 2026 |
| New Jersey | $6.57 | -- | Not required | 2026 |
| New Mexico | $7.57 | -- | -- | 2025 |
| Oklahoma | $7.57 | -- | -- | 2026 |
| South Carolina | $6.53 | -- | -- | 2025 |
| Utah | $7.57* | -- | Not required | 2024 |
| Virginia | $7.56 | -- | -- | 2024 |
| Vermont | $7.19 | -- | Required | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 52 codes from Q0035 to Q0506 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q0249?
19 state Medicaid programs publish a fee-for-service rate for Q0249 (injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg), ranging from $5.96 in Iowa to $7.57 in Arizona. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q0249?
Arizona publishes the highest Medicaid rate for Q0249 at $7.57. Iowa publishes the lowest at $5.96.
Does Q0249 require prior authorization under Medicaid?
1 of the 19 publishing states flag Q0249 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".